AGTC
AGTC Announces New Corporate Office and Laboratory Facility
Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, recently announced the opening of a new combined use corporate office and laboratory facility in the rapidly growing North Central Florida biotech corridor. AGTC was founded based on technology developed at...
AGTC Selected to the University of Florida's 2016 Gator100
Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced in February that the company has been selected to the 2016 Gator100. The Gator100, named after the University of Florida’s mascot, annually recognizes and celebrates the 100 fastest-growing businesses in...
USR Systems expands in Gainesville, adds 140 new jobs
Governor Rick Scott announced that USR Systems, a U.S.-based IT consulting services company, will be expanding in Gainesville to create 140 new jobs. USR Systems specializes in mobility, cloud enablement, digital transformation, business intelligence, data analytics and testing. The new positions will support USR’s goal of ultimately building a delivery center in Gainesville. Governor Scott...
AGTC and Synpromics Limited Announce R&D Collaboration to Develop Synthetic Promoters for Enhanced Gene Therapy Candidates
Applied Genetic Technologies Corporation a biotechnology company conducting human clinical trials of adeno-associated virus-based gene therapies for the treatment of rare eye diseases, and Synpromics Limited, a leading synthetic promoter development company backed by Calculus Capital, announced they have entered into a broad, multi-target collaboration agreement. Potential payments to be made by AGTC to Synpromics...
AGTC research based operations leads to strategic partnerships
Applied Genetic Technologies Corporation, commonly referred to as AGTC, is an Alachua County based company that rose to national prominence when a collaboration deal with pharmaceutical giant Biogen was announced last summer. Shares of AGTC are publicly traded on the NASDAQ market and the company is worth $226 million, according to October 23 market closing...
AGTC Continues to Expand Management Team With Three Key Hires
GAINESVILLE, Fla., Oct. 5, 2015 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical-stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today announced the appointment of three new employees. Among these hires, Jonathan M. Sparks, Ph.D. will join AGTC as Vice President of Legal Affairs. The Company also announced the appointments...
Financial Year In Review
2014: End Remarks By WJ Rossi, CFP®, ChFC Since the beginning of the calendar year, many economic trends have taken place. Long-term interest rates came down, but the US dollar strengthened as investors saw the United States as the best place to put their money. Slowdown in Gross Domestic Product (GDP) growth in China and...